{
  "id": 16807106,
  "title": "Lyme Disease Vaccine Candidate Just Misses Its Mark in Late-Stage Trial",
  "url": "https://urgent.news/2026/10/27/lyme-disease-vaccine-candidate-just-misses-its-mark-in-late-stage",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-27T21:12:08.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/idweek/123610"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- WASHINGTON -- An investigational Lyme disease vaccine covering six serotypes across four Borrelia species had a vaccine efficacy (VE) rate of over 70%, but it just missed a preset noninferiority threshold, a placebo-controlled...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}